Education
About Us
Working with TipRanks
Follow Us
Inspire Medical Systems (INSP)
NYSE:INSP
Total Valuation
Inspire Medical Systems has a market cap or net worth of $4.39B. The enterprise value is $5.29B.
Market Cap$4.39B
Enterprise Value$5.29B
Share Statistics
Inspire Medical Systems has 29,759,651 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,759,651
Owned by Insiders1.23%
Owned by Institutions1.31%
Financial Efficiency
Inspire Medical Systems’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.59%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)4.59%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee644.30K
Profits Per Employee42.94K
Employee Count1,246
Asset Turnover0.99
Inventory Turnover1.54
Valuation Ratios
The current PE Ratio of Inspire Medical Systems is 103.11. Inspire Medical Systems’s PEG ratio is -0.29.
PE Ratio103.11
PS Ratio6.09
PB Ratio8.00
Price to Fair Value8.00
Price to FCF60.55
Price to Operating Cash Flow42.36
PEG Ratio-0.29
Income Statement
In the last 12 months, Inspire Medical Systems had revenue of 802.80M and earned 53.51M in profits. Earnings per share was 1.80.
Revenue802.80M
Gross Profit679.82M
Operating Income36.08M
Pretax Income58.45M
Net Income53.51M
EBITDA65.03M
Earnings Per Share (EPS)1.80
Cash Flow
In the last 12 months, operating cash flow was 130.25M and capital expenditures -39.12M, giving a free cash flow of 91.12M billion.
Operating Cash Flow130.25M
Free Cash Flow91.12M
Free Cash Flow per Share3.06
Dividends & Yields
Inspire Medical Systems pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.79
52-Week Price Change-33.01%
50-Day Moving Average165.05
200-Day Moving Average181.39
Relative Strength Index (RSI)53.19
Average Volume (3m)478.99K
Important Dates
Inspire Medical Systems upcoming earnings date is May 5, 2025, TBA Not Confirmed.
Last Earnings DateFeb 10, 2025
Next Earnings DateMay 5, 2025
Ex-Dividend Date―
Financial Position
Inspire Medical Systems as a current ratio of 7.13, with Debt / Equity ratio of 4.36%
Current Ratio7.13
Quick Ratio6.22
Debt to Market Cap<0.01
Net Debt to EBITDA-1.85
Interest Coverage Ratio1.64K
Taxes
In the past 12 months, Inspire Medical Systems has paid 4.94M in taxes.
Income Tax4.94M
Effective Tax Rate0.08
Enterprise Valuation
Inspire Medical Systems EV to EBITDA ratio is 83.01, with an EV/FCF ratio of 59.23.
EV to Sales6.72
EV to EBITDA83.01
EV to Free Cash Flow59.23
EV to Operating Cash Flow41.44
Balance Sheet
Inspire Medical Systems has $445.55M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$415.51M billion.
Cash & Marketable Securities$445.55M
Total Debt$0.00
Net Cash-$415.51M
Net Cash Per Share-$13.96
Tangible Book Value Per Share$23.17
Margins
Gross margin is 84.68%, with operating margin of 4.49%, and net profit margin of 6.67%.
Gross Margin84.68%
Operating Margin4.49%
Pretax Margin7.28%
Net Profit Margin6.67%
EBITDA Margin8.10%
EBIT Margin7.28%
Analyst Forecast
The average price target for Inspire Medical Systems is $221.64, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$221.64
Price Target Upside39.34% Upside
Analyst ConsensusStrong Buy
Analyst Count14
Revenue Growth Forecast28.49%
EPS Growth Forecast―